Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alkermes ( (ALKS) ) has issued an announcement.
At its annual general meeting on May 20, 2026, Alkermes shareholders approved amendments to the company’s 2018 Stock Option and Incentive Plan, increasing the ordinary shares authorized for issuance under the plan by 5.9 million and formally ratifying the updated plan. Shareholders also re-elected all nominated directors for one-year terms through the 2027 meeting, endorsed executive compensation in an advisory vote, ratified PricewaterhouseCoopers LLP as independent auditor with authority for the Audit and Risk Committee to set its fees, and renewed the board’s authority to allot shares and disapply statutory pre-emption rights under Irish law, collectively reinforcing the company’s capital flexibility, governance continuity, and executive incentives framework.
The most recent analyst rating on (ALKS) stock is a Buy with a $48.00 price target. To see the full list of analyst forecasts on Alkermes stock, see the ALKS Stock Forecast page.
Spark’s Take on ALKS Stock
According to Spark, TipRanks’ AI Analyst, ALKS is a Neutral.
Overall score reflects solid but mixed fundamentals: strong product momentum and upbeat adjusted-EBITDA guidance support the outlook, while a major step-up in leverage and weaker recent free-cash-flow/margin trends increase risk. Technicals are constructive, but valuation is less supportive due to the negative P/E and lack of dividend yield data.
To see Spark’s full report on ALKS stock, click here.
More about Alkermes
Alkermes plc is a biopharmaceutical company focused on developing and commercializing medicines, with its ordinary shares listed and governed in part under Irish law. The company uses equity-based incentive plans and maintains a board of directors elected annually by shareholders, reflecting a conventional governance and compensation structure for its sector.
Average Trading Volume: 2,411,207
Technical Sentiment Signal: Buy
Current Market Cap: $6.2B
For a thorough assessment of ALKS stock, go to TipRanks’ Stock Analysis page.